Want to see GB:MYX full AI Analyst Report?
Top Page
MyCelx Technologies
(LSE:MYX)
Select Model
Select Model
Rating:50Neutral
Price Target:
47.00 p
▲(74.07% Upside)
Action:Reiterated
Date:10/09/26
The score is held back primarily by weak cash-flow performance (ongoing negative operating and free cash flow) despite a notable 2025 revenue and profitability rebound. Technicals are also a headwind with the price below key short/medium-term moving averages, while valuation appears roughly moderate based on a ~20.7 P/E without dividend support.
Positive Factors
2025 Revenue and Profit Rebound
The sharp 2025 revenue increase and return to profitability show that the company can generate meaningful demand and earnings when project activity improves. If this rebound persists, it could rebuild operating scale, support reinvestment, and strengthen the commercial base over the next several quarters.
Negative Factors
Persistent Negative Cash Flow
MyCelx has not yet demonstrated consistent conversion of reported earnings into cash, even after returning to accounting profitability. Persistent operating and free cash outflows can pressure liquidity, increase reliance on funding, and constrain the company’s ability to sustain investment through weaker project periods.
Read all positive and negative factors
Positive Factors
Negative Factors
2025 Revenue and Profit Rebound
The sharp 2025 revenue increase and return to profitability show that the company can generate meaningful demand and earnings when project activity improves. If this rebound persists, it could rebuild operating scale, support reinvestment, and strengthen the commercial base over the next several quarters.
Read all positive factors
MyCelx Technologies (MYX) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£11.33M
Dividend YieldN/A
Average Volume (3M)26.93K
Price to Earnings (P/E)21.0
Beta (1Y)0.21
Revenue GrowthN/A
EPS GrowthN/A
CountryUK
Employees18
SectorIndustrials
Sector Strength72
IndustryIndustrial - Pollution & Treatment Controls
Share Statistics
EPS (TTM)0.03
Shares Outstanding24,363,813
10 Day Avg. Volume13,651
30 Day Avg. Volume26,928
Financial Highlights & Ratios
PEG Ratio-0.34
Price to Book (P/B)1.56
Price to Sales (P/S)0.75
P/FCF Ratio-9.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)£11.00M
MyCelx Technologies Business Overview & Revenue Model
Company Description
MYCELX Technologies Corporation is a clean water technology firm that provides water purification systems to a wide array of industries, including the petroleum, power generation, maritime, and heavy manufacturing sectors. The company operates glo...
How the Company Makes Money
MyCelx makes money primarily by selling and deploying its proprietary filtration media and the associated water treatment equipment/systems that use that media. Revenue is generated through (1) product sales of MyCelx filtration media (consumable ...
MyCelx Technologies Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
66
Positive
Cash Flow
33
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.18M | 11.74M | 4.90M | 10.91M | 10.03M | 8.48M |
| Gross Profit | 6.15M | 5.62M | 1.34M | 3.89M | 4.44M | 3.27M |
| EBITDA | 1.77M | 1.11M | -2.23M | -2.46M | -2.48M | 19.00K |
| Net Income | 815.00K | 334.00K | -2.72M | -3.71M | -3.99M | -1.43M |
Balance Sheet | ||||||
| Total Assets | 8.77M | 8.67M | 10.05M | 10.39M | 13.62M | 15.66M |
| Cash, Cash Equivalents and Short-Term Investments | 499.00K | 812.00K | 1.26M | 383.00K | 1.65M | 3.13M |
| Total Debt | 1.12M | 1.26M | 1.26M | 889.00K | 1.22M | 1.47M |
| Total Liabilities | 4.52M | 3.01M | 4.79M | 3.23M | 2.79M | 3.04M |
| Stockholders Equity | 4.25M | 5.66M | 5.26M | 7.16M | 10.83M | 12.62M |
Cash Flow | ||||||
| Free Cash Flow | -644.00K | -898.00K | -2.20M | -1.21M | -3.53M | -3.80M |
| Operating Cash Flow | -576.00K | -863.00K | -2.15M | -1.11M | -2.69M | -3.43M |
| Investing Cash Flow | -68.00K | -35.00K | 2.24M | -181.00K | -842.00K | 5.08M |
| Financing Cash Flow | 500.00K | 450.00K | 792.00K | 0.00 | 2.04M | -2.24M |
MyCelx Technologies Technical Analysis
Negative
27.00
Price Trends
52.05
Negative
54.46
Negative
51.16
Negative
Market Momentum
-2.00
Positive
33.72
Neutral
19.54
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:MYX, the sentiment is Negative. The current price of 27 is below the 20-day moving average (MA) of 48.67, below the 50-day MA of 52.05, and below the 200-day MA of 51.16, indicating a bearish trend. The MACD of -2.00 indicates Positive momentum. The RSI at 33.72 is Neutral, neither overbought nor oversold. The STOCH value of 19.54 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:MYX.
MyCelx Technologies Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £389.05M | 21.05 | 10.96% | 0.82% | 3.47% | 10.35% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | £52.80M | 14.42 | 6.10% | ― | 4.01% | -4.27% | |
53 Neutral | £222.06M | 741.63 | 0.86% | 1.60% | -13.43% | ― | |
51 Neutral | £50.73M | -14.56 | -5.87% | 2.02% | 20.26% | 89.85% | |
50 Neutral | £11.33M | 20.96 | 16.44% | ― | ― | ― | |
50 Neutral | £519.59M | -19.47 | -11.09% | ― | 67.62% | 45.05% |
* Industrials Sector Average
GB:MYX
MyCelx Technologies
46.50
21.00
82.35%
GB:DIA
Dialight
554.00
296.00
114.73%
GB:FLO
Flowtech Fluidpower
62.60
4.70
8.12%
GB:ITM
ITM Power
75.15
-3.85
-4.87%
GB:PRV
Porvair
842.00
82.91
10.92%
GB:WATR
Water Intelligence
280.00
17.00
6.46%
MyCelx Technologies Corporate Events
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
MYCELX Delays Revenue to 2027 as Project Slips and Customer Disruption Hit 2026
Negative
Oct 8, 2026
MYCELX Technologies has warned that around $2 million of revenue expected for 2026 will now be recognized in 2027 after a major Middle Eastern customer failed to issue a purchase order within the fabrication window, delaying delivery of a signific...
Executive/Board ChangesShareholder Meetings
MYCELX Shareholders Back Board, Auditor and Pay at Adjourned AGM
Positive
Oct 1, 2026
MYCELX Technologies Corporation reported that all resolutions at its adjourned Annual Meeting on 1 October 2026 in Norcross, Georgia were passed on a poll, including the election of directors Tom Lamb, Connie Mixon, Haluk Alper and Torben Wetche. ...
Shareholder Meetings
MyCelx Adjourns Annual Meeting After Failing to Reach Quorum
Neutral
Sep 17, 2026
MyCelx Technologies Corporation opened its Annual Meeting on 17 September 2026 in London, but was forced to adjourn after failing to reach the quorum required under its bylaws, which demand participation from shareholders representing more than 50...
Business Operations and StrategyFinancial Disclosures
MYCELX Marks Inflection Point as Contract Pipeline Triples on New Oil Major Approval
Positive
Sep 17, 2026
MYCELX Technologies Corporation says it has reached a key inflection point after several years of development, with the last eight months bringing a major expansion in its sales opportunity pipeline. The company’s technology has now been app...
Business Operations and StrategyFinancial Disclosures
MyCelx boosts H1 revenue and secures key produced water contracts
Positive
Sep 10, 2026
MyCelx Technologies reported a 26% rise in first-half 2026 revenue to $2.1 million, driven by paid trials, equipment leases and recurring media sales that lifted gross margin to 57%, while losses narrowed versus the prior year. Operationally, the ...
Shareholder Meetings
MYCELX Sends 2026 Annual Meeting Notice to Shareholders
Neutral
Aug 3, 2026
MYCELX Technologies Corporation has mailed the Notice of its 2026 Annual Meeting to shareholders, following the June distribution of its 2025 Annual Report. The notice is available on the company’s website and at its Norcross, Georgia headqu...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
MYCELX Targets Strong H2 as Permian and Offshore Water Projects Build Momentum
Positive
Jul 30, 2026
MYCELX reported unaudited H1 2026 revenue of about $2.1 million, up from $1.7 million a year earlier, driven by paid trials, leases and recurring media sales. Management expects a significantly stronger second half, underpinned by a $3.9 million R...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.